U.K. Regulatory Agency's Move Draws Industry Attention
This article was originally published in The Tan Sheet
Executive Summary
Drug industry stakeholders in European Union markets will watch carefully in October when the U.K.'s regulator moves to a new office, with OTC marketers having reason to pay particularly close attention
You may also be interested in...
MHRA Fields Team To Focus On Nonprescription Drug Reviews
The U.K. health authority launches a team dedicated to processing nonprescription products to offset demand for the agency's Rx reviews generated by the European Regulatory Network's decentralized procedure
European OTC Market Conference In Brief
Countries expand nonprescription sales: Italy and Hungary ease regulations for sales of nonprescription drugs. Drug companies and stores in Italy now can price nonprescription drugs as they wish as long as the amounts do not exceed prices set in December 2006 and are visible at points of sale, Guido Rasi, director general of the Italian Medicines Agency, said at the Association of the European Self-Medication Industry's (AESGP) Nov. 5 conference in Paris. Rasi added that retail prices also can be discounted. Through October 2008 in Hungary, 701 licensed non-pharmacy outlets were selling nonprescription products, including analgesics and vitamins, said Zsuzanna Szepezdi, director general of the country's National Institute of Pharmacy. She explained that Hungary eased nonprescription sales regulations in early 2007 so that some products can be sold outside the pharmacy if they are stored in closed cupboards and information about the products is available via electronic information systems
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC